Origent Receives NIH SBIR Award to Develop Methods for Prediction-Based Enrichment of Human Clinical Trials
Origent Data Sciences has been awarded a Phase 1 Small Business Innovation Research (SBIR) award from the NIH National Institute of Mental Health. The grant award project, titled “A Clinical Trial Enrichment Tool Based on Subgroups Defined by Machine Learning...
Press Release: Cytokinetics announces New Data Presented at the International Symposium on ALS/MND
Click here for a printer-friendly version. Cytokinetics announces New Data Presented at the International Symposium on ALS/MND Baseline Characteristics and Demographics from FORTITUDE-ALS Similar to Other Recent Large Trials in ALS SOUTH SAN FRANCISCO, Calif.,...
Press Release: Mitsubishi Tanabe Pharma America Announces Collaborative Study To Identify And Measure Biomarkers In People With ALS
Click here for printer-friendly version. Mitsubishi Tanabe Pharma America Announces Collaborative Study To Identify And Measure Biomarkers In People With ALS Findings Will Help Further Understanding of ALS Disease Progression and Treatment Effect JERSEY CITY,...
Origent’s Dr. David Ennist Joins Panel at ALSA Community Workshop
Origent’s Chief Science Officer Dr. David Ennist will join several other ALS community leaders as a panelist at the ALS Community Workshop with the theme Developing Drugs for Treatment; Guidance for Industry. This ALSA-led event, which will occur on July 12,...